Ultragenyx Pharmaceutical Files 8-K
Ticker: RARE · Form: 8-K · Filed: 2026-04-02T08:45:09-04:00
Sentiment: neutral
Topics: 8-k, regulatory-filing
Related Tickers: UXAS
TL;DR
UXAS filed an 8-K, no major news yet.
AI Summary
Ultragenyx Pharmaceutical Inc. filed an 8-K on April 2, 2026, reporting other events. The filing does not contain specific financial figures or new material agreements at this time.
Why It Matters
This filing indicates Ultragenyx is providing an update or disclosing information beyond routine quarterly reports, which could be significant for investors monitoring company developments.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and does not disclose any immediate financial risks or significant negative developments.
Key Players & Entities
- Ultragenyx Pharmaceutical Inc. (company) — Filer
- 0001515673 (company) — CIK
- 2026-04-02 (date) — Filing Date
FAQ
What is the purpose of this 8-K filing?
This 8-K filing is for 'Other Events' as per Item 8.01, indicating Ultragenyx Pharmaceutical Inc. is disclosing information beyond routine events.
When was this 8-K filing accepted by the SEC?
The filing was accepted on April 2, 2026, at 08:45:09.
What is Ultragenyx Pharmaceutical Inc.'s CIK number?
Ultragenyx Pharmaceutical Inc.'s CIK number is 0001515673.
What is the business address of Ultragenyx Pharmaceutical Inc.?
The business address is 60 LEVERONI COURT NOVATO CA 94949.
What SIC code is associated with Ultragenyx Pharmaceutical Inc.?
The SIC code is 2834 for Pharmaceutical Preparations.
From the Filing
EDGAR Filing Documents for 0001193125-26-139084 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001193125-26-139084 Filing Date 2026-04-02 Accepted 2026-04-02 08:45:09 Documents 9 Period of Report 2026-04-02 Items Item 8.01: Other Events Interactive Data Document Format Files Seq Description Document Type Size 1 8-K rare-20260402.htm iXBRL 8-K 51723 Complete submission text file 0001193125-26-139084.txt 154700 Data Files Seq Description Document Type Size 2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rare-20260402.xsd EX-101.SCH 23898 12 EXTRACTED XBRL INSTANCE DOCUMENT rare-20260402_htm.xml XML 4516 Mailing Address 60 LEVERONI COURT NOVATO CA 94949 Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800 Ultragenyx Pharmaceutical Inc. (Filer) CIK : 0001515673 (see all company filings) EIN. : 272546083 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 26830778 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)